Net Loss of Aspira Pathlab & Diagnostics reported to Rs 0.02 crore in the quarter ended June 2024 as against net loss of Rs 0.72 crore during the previous quarter ended June 2023. Sales rose 78.46% to Rs 4.64 crore in the quarter ended June 2024 as against Rs 2.60 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 4.64 | 2.60 | 78 |
| OPM % | 7.54 | -12.69 | - |
| PBDT | 0.36 | -0.33 | LP |
| PBT | -0.02 | -0.72 | 97 |
| NP | -0.02 | -0.72 | 97 |